Clinical Trial Update: A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating IBD0333 in patients with advanced malignant tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IBD0333 (IBD0333)

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: MTD | Phase 1, Phase 2 | Status: RECRUITING